Clinical Trial to Slow the Progression of ADPKD

The recruitment status of this study is unknown because the information has not been verified recently.

Verified November 2005 by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Recruitment status was Not yet recruiting

Sponsor:

Information provided by:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

ClinicalTrials.gov Identifier:

NCT00067977

First received: September 3, 2003

Last updated: November 2, 2005

Last verified: November 2005

History of Changes

Purpose

This study will determine whether certain blood pressure medications will slow cyst growth or keep kidneys functioning longer in patients with autosomal dominant polycystic kidney disease (ADPKD). The study will take place at several sites in the United States. The start date of the study has not yet been determined.

Condition	Intervention
Kidney, Polycystic Kidney, Polycystic, Autosomal Dominant	Drug: anti-hypertensive medications


Study Type:	Interventional
Study Design:	Primary Purpose: Treatment

Resource links provided by NLM:

Genetics Home Reference related topics: polycystic kidney disease

MedlinePlus related topics: Kidney Diseases

U.S. FDA Resources

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Eligibility


Ages Eligible for Study:	15 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Previous diagnosis of autosomal dominant polycystic kidney disease by abdominal imaging
Previous diagnosis of high blood pressure or current blood pressures above 130/80 mm Hg

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00067977

Locations


United States, Colorado
University of Colorado Health Sciences Center	Not yet recruiting
Denver, Colorado, United States, 80262
Contact: Lyn Tison 877-765-9297
United States, Georgia
Emory University	Not yet recruiting
Atlanta, Georgia, United States
Contact 404-370-7344
United States, Kansas
Kansas University Medical Center	Not yet recruiting
Kansas City, Kansas, United States
Contact 913-588-7609
United States, Massachusetts
Beth Israel Deaconess Medical Center	Not yet recruiting
Boston, Massachusetts, United States
Tufts - New England Medical Center	Not yet recruiting
Boston, Massachusetts, United States
Contact 617-636-8763
United States, Minnesota
Mayo Clinic	Not yet recruiting
Rochester, Minnesota, United States
Contact 507-284-0944
United States, Ohio
Cleveland Clinic Foundation	Not yet recruiting
Cleveland, Ohio, United States
Contact 800-223-2273 ext 44680

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

More Information

No publications provided


ClinicalTrials.gov Identifier:	NCT00067977 History of Changes
Other Study ID Numbers:	ADPKD
Study First Received:	September 3, 2003
Last Updated:	November 2, 2005
Health Authority:	United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):


PKD ADPKD polycystic kidney disease autosomal dominant polycystic kidney disease

Additional relevant MeSH terms:


Multicystic Dysplastic Kidney Polycystic Kidney Diseases Polycystic Kidney, Autosomal Dominant Congenital Abnormalities	Kidney Diseases Kidney Diseases, Cystic Urogenital Abnormalities Urologic Diseases

ClinicalTrials.gov processed this record on March 03, 2015

To Top